| מסגרת זמן | מחיר חזוי | עָבָר | הִיסטוֹרִי | תוֹבָנָה |
|---|---|---|---|---|
| מָחָר | $3.13 ▼ -0.97% | אֶתמוֹל | $3.17 ▲ +0.41% | Tomorrow's Tvardi Therapeutics Inc. Common Stock (TVRD) setup is anchored to $3.16 and targets $3.13 (-0.97%). The near-term read is downside; watch $3.25 / $3.07 because daily realized volatility is about 5.01%. |
Tomorrow's Tvardi Therapeutics Inc. Common Stock (TVRD) setup is anchored to $3.16 and targets $3.13 (-0.97%). The near-term read is downside; watch $3.25 / $3.07 because daily realized volatility is about 5.01%. | ||||
| שָׁבוּעַ | $3.06 ▼ -3.02% | שבוע שעבר | $3.20 ▲ +1.27% | The 7-day Tvardi Therapeutics Inc. Common Stock model moves from $3.20 to $3.06 (-3.02%). It gives downside momentum context for this stock, so breaks around $3.25 / $3.07 matter more than a single tick. |
The 7-day Tvardi Therapeutics Inc. Common Stock model moves from $3.20 to $3.06 (-3.02%). It gives downside momentum context for this stock, so breaks around $3.25 / $3.07 matter more than a single tick. | ||||
| חוֹדֶשׁ | $2.96 ▼ -6.44% | חודש שעבר | $3.25 ▲ +2.71% | The 1-month Tvardi Therapeutics Inc. Common Stock target is $2.96 (-6.44%), compared with the live reference near $3.16. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Tvardi Therapeutics Inc. Common Stock target is $2.96 (-6.44%), compared with the live reference near $3.16. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| שָׁנָה | $2.79 ▼ -11.57% | אֶשׁתָקַד | $3.31 ▲ +4.86% | The 1-year Tvardi Therapeutics Inc. Common Stock scenario points to $2.79 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Tvardi Therapeutics Inc. Common Stock scenario points to $2.79 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 שנים | $2.42 ▼ -23.57% | לפני 5 שנים | $3.47 ▲ +9.90% | The 5-year Tvardi Therapeutics Inc. Common Stock view is $2.42 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Tvardi Therapeutics Inc. Common Stock view is $2.42 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| מַד | עֵרֶך | אוֹת |
|---|---|---|
| Price | $3.16 | Mid |
| Daily Change | -1.86% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 61% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $3.16 | Daily Change | -1.86% |
| Market Cap | $29.65M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.